Physician profile
Matthew J Tormenti
NPI 1831396357
$5,701.95
in general payments reported to CMS, 2019-2025
14 companies · $354 in 2025
The $354 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $834 · 2020: $380 · 2021: $678 · 2022: $1,537 · 2023: $1,119 · 2024: $800 · 2025: $354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,750 · Food and Beverage: $523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,750.00 |
| Food and Beverage | $522.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $2,254.60 | 2022-2024 | Cusa Clarity, Codman Certas, Codman Hakim |
| Nevro Corp. | $1,250.17 | 2019-2024 | Senza |
| Boston Scientific Corporation | $783.64 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Stryker Corporation | $261.64 | 2022-2023 | Prolift |
| Nuvasive, INC. | $253.13 | 2020 | |
| Si-Bone, INC. | $232.53 | 2020-2022 | |
| Electronic Waveform Lab, INC. | $211.78 | 2021 | |
| Globus Medical, INC. | $167.26 | 2025 | Senza |
| Orthofix Medical, INC. | $80.73 | 2019 | |
| Baxter Healthcare | $69.26 | 2021 | |
| Alphatec Spine, INC | $42.43 | 2025 | Other - Miscellaneous |
| Medtronic, INC. | $42.00 | 2025 | |
| Allergan, INC. | $27.80 | 2021 | |
| Abbott Laboratories | $24.98 | 2024 | Proclaim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Tormenti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.